Oxford Biomedica (LON:OXB) Stock Price Up 0.1% – Still a Buy?

Oxford Biomedica plc (LON:OXB)’s share price rose 0.1% on Wednesday . The stock traded as high as GBX 433.44 ($5.47) and last traded at GBX 430 ($5.43). Approximately 92,890 shares were traded during trading, a decline of 54% from the average daily volume of 201,557 shares. The stock had previously closed at GBX 429.50 ($5.42).

Analyst Ratings Changes

Separately, Deutsche Bank Aktiengesellschaft raised their price objective on shares of Oxford Biomedica from GBX 250 ($3.16) to GBX 380 ($4.80) and gave the stock a “hold” rating in a report on Tuesday, September 24th.

Oxford Biomedica Stock Down 1.5 %

The company has a market cap of £446.20 million, a P/E ratio of -294.10 and a beta of 1.09. The company has a quick ratio of 1.67, a current ratio of 2.35 and a debt-to-equity ratio of 154.88. The firm has a fifty day moving average price of GBX 411.09 and a 200 day moving average price of GBX 364.39.

Oxford Biomedica Company Profile

Oxford Biomedica plc, a contract development and manufacturing organization, focuses on delivering therapies to patients worldwide. Its s LentiVector platform technology is an advanced lentiviral vector based gene delivery system which is designed to overcome the safety and delivery problems associated with earlier generations of vector systems.